论文部分内容阅读
目的对中西医药物联合法治疗乳腺癌进行疗效观察。方法选取2013年1~12月期间在本院接受治疗的乳腺癌患者90例,分为实验组与对照组。实验组患者45例,采用氟尿嘧啶(CAF)、环磷酰胺、阿霉素与参芪扶正注射液联合法进行治疗;对照组给予氟尿嘧啶(CAF)、环磷酰胺、阿霉素进行联合治疗,对比两组患者的临床治疗效果,对中西医药物联合法治疗乳腺癌的效果进行判定。结果两组患者的治疗效果在临床上均得以体现,Karnofsky评分上,实验组显著高于对照组,两组数据差异具有统计学意义(P<0.05)。结论中西医药物联合法在治疗乳腺癌方面效果显著,具有较高的临床应用价值。
Objective To observe the curative effect of combined treatment of traditional Chinese and western medicine on breast cancer. Methods Totally 90 breast cancer patients treated in our hospital from January to December in 2013 were divided into experimental group and control group. Forty-five patients in the experimental group were treated with fluorouracil (CAF), cyclophosphamide, doxorubicin and Shenqi Fuzheng injection. The control group received combined treatment of fluorouracil (CAF), cyclophosphamide and doxorubicin Clinical efficacy of two groups of patients, the combination of traditional Chinese and Western medicine treatment of breast cancer to determine the effect. Results The therapeutic effect of both groups was clinically demonstrated. The Karnofsky score was significantly higher in the experimental group than in the control group, with significant difference between the two groups (P <0.05). Conclusion The combination of Chinese and Western medicine in the treatment of breast cancer effect is significant, with high clinical value.